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Abstract
Background  and  objectives:  The  local  anesthetic  effects  on  neuromuscular  junction  and  its
inﬂuence on  blockade  produced  by  nondepolarizing  neuromuscular  blockers  are  still  under-
investigated;  however,  this  interaction  has  been  described  in  experimental  studies  and  in
humans.  The  aim  of  this  study  was  to  evaluate  in  vitro  the  interaction  between  ropivacaine  and
pancuronium,  the  inﬂuence  on  transmission  and  neuromuscular  blockade,  and  the  effectiveness
of neostigmine  and  4-aminopyridine  to  reverse  the  blockade.
Methods:  Rats  were  divided  into  groups  (n  =  5)  according  to  the  study  drug:  ropiva-
caine (5  g  mL−1);  pancuronium  (2  g  mL−1);  ropivacaine  +  pancuronium.  Neostigmine  and
4-aminopyridine  were  used  at  concentrations  of  2  g  mL−1 and  20  g  mL−1,  respectively.  The
effects of  ropivacaine  on  membrane  potential  and  miniature  endplate  potential,  the  amplitude
of diaphragm  responses  before  and  60  min  after  the  addition  of  ropivacaine  (degree  of  neuro-
muscular blockade  with  pancuronium  and  with  the  association  of  pancuronium--ropivacaine),
and the  effectiveness  of  neostigmine  and  4-aminopyridine  on  neuromuscular  block  reversal
were evaluated. Study performed at the Department of Anesthesiology and Pharmacology, Campinas State University (UNICAMP) School of Medicine,
ampinas, SP, Brazil.
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Results:  Ropivacaine  did  not  alter  the  amplitude  of  muscle  response  (the  membrane  potential),
but decreased  the  frequency  and  amplitude  of  the  miniature  endplate  potential.  Pancuronium
blockade was  potentiated  by  ropivacaine,  and  partially  and  fully  reversed  by  neostigmine  and
4-aminopyridine,  respectively.
Conclusions:  Ropivacaine  increased  the  neuromuscular  block  produced  by  pancuronium.  The
complete antagonism  with  4-aminopyridine  suggests  presynaptic  action  of  ropivacaine.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Efeito  da  associac¸ão  ropivacaina-pancurônio  na  transmissão  neuromuscular  e  eﬁcácia
da  neostigmine  e  4-aminopiridina  na  reversão  do  bloqueio:  estudo  experimental
Resumo
Justiﬁcativa  e  objetivos:  Os  efeitos  dos  anestésicos  locais  na  junc¸ão  neuromuscular  e  sua
inﬂuência  no  bloqueio  produzido  por  bloqueadores  neuromusculares  não-despolarizantes  é
ainda alvo  de  pouca  investigac¸ão,  no  entanto  esta  interac¸ão  tem  sido  descrita  em  trabalhos
experimentais  e  em  humanos.  O  objetivo  deste  estudo  foi  avaliar  in  vitro,  a  interac¸ão  da  ropi-
vacaína com  o  pancurônio,  a  inﬂuência  na  transmissão  e  bloqueio  neuromuscular  e  a  efetividade
da neostigmina  e  4-aminopiridina  na  reversão  do  bloqueio.
Método:  Ratos  foram  distribuídos  em  grupos  (n  =  5)  de  acordo  com  o  fármaco  estudado:
ropivacaína  (5  g  mL−1);  pancurônio  (2  g  mL−1);  ropivacaína  +  pancurônio.  A  neostigmina  e  a
4-aminopiridina  foram  usadas  nas  concentrac¸ões  de  2  g  mL−1 e  20  g  mL−1,  respectivamente.
Avaliou-se:  1)  efeitos  da  ropivacaína  sobre  o  potencial  de  membrana  e  potenciais  de  placa
terminal  em  miniatura;  2)  a  amplitude  das  respostas  do  diafragma  antes  e  60  minutos  após  a
adic¸ão da  ropivacaína;  o  grau  de  bloqueio  neuromuscular  com  o  pancurônio  e  com  a  associac¸ão
pancurônio  -  ropivacaína;  3)  a  efetividade  da  neostigmina  e  4-aminopiridina  na  reversão  do
bloqueio  neuromuscular.
Resultados:  A  ropivacaína  não  alterou  a  amplitude  das  respostas  musculares,  os  potenciais  de
membrana,  mas  diminuiu  a  frequência  e  a  amplitude  dos  potenciais  de  placa  terminal  em
miniatura.  O  bloqueio  produzido  pelo  pancurônio  foi  potencializado  pela  ropivacaína,  e  parcial
e totalmente  revertido  pela  neostigmina  e  4-aminopiridina,  respectivamente.
Conclusões:  A  ropivacaína  potencializou  o  bloqueio  neuromuscular  produzido  pelo  pan-
curônio. O  antagonismo  completo  com  a  4-aminopiridina  sugere  ac¸ão  pré-sináptica  da
ropivacaína.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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MethodIntroduction
Local  anesthetics,  particularly  amino  amides,  are  a  group
of  drugs  widely  administered  by  different  routes,  such  as
topical,  subcutaneous  inﬁltration,  peripheral  nerve  block,
neuraxial  anesthesia  alone  or  combined  with  general
anesthesia.1--4
There  is  evidence  that  these  drugs  may  interfere  with
neuromuscular  transmission  and  increase  the  effects  of  neu-
romuscular  blockers.1--7
Ropivacaine  is  an  amino-amide  local  anesthetic  with  simi-
lar  physicochemical  properties  to  bupivacaine  (S50%--R50%),
except  for  the  lower  potency  and  lesser  degree  of  motor
blockade,  with  greater  selectivity  for  sensory  nerve  ﬁbers,
characteristics  attributed  to  its  lower  lipid  solubility  and
pure  S− isomer  structure  as  opposed  to  the  racemic  mixture
of  bupivacaine.8,9
T
dThese  characteristics  are  also  responsible  for  less  cardiac
nd  central  nervous  system  toxicity,  ropivacaine  advantages
ver  bupivacaine  (S50%--R50%).8,9 Pancuronium  is  a  long  act-
ng  nondepolarizing  aminostreroid  neuromuscular  blocker,
hich  justiﬁes  its  use  in  prolonged  surgery  and  intensive
are.10
The  aim  of  this  study  was  to  evaluate  in  an  experimental
odel  the  effect  of  ropivacaine  on  neuromuscular  trans-
ission,  its  inﬂuence  on  the  neuromuscular  block  produced
y  pancuronium,  and  the  effectiveness  of  neostigmine  and
-aminopyridine  on  blockade  reversal.his  is  an  in  vitro  experimental  study  in  which  the  proce-
ures  used  were  in  accordance  with  the  ethical  principles
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Figure  1  Amplitude  of  muscle  response  to  indirect  stimula-
tion on  phrenic  nerve-diaphragm  preparation  of  rats  exposed  to
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izing  neuromuscular  blockers  are  still  under-investigated;opivacaine  (5.0  g  mL ),  pancuronium  (2  g  mL ),  and  ropi-
acaine  +  pancuronium.
f  animal  experimentation  adopted  by  the  Brazilian  College
f  Animal  Experimentation  (COBEA),  approved  by  the  Ani-
al  Research  Ethics  Committee  of  the  Institute  of  Biology,
ampinas  State  University  (protocol  No.  2346-1).
Male  Wistar  rats  weighing  between  180  and  250  g  were
sed.  The  animals  were  anesthetized  intraperitoneally  with
rethane  (1.2  mg  kg−1),  followed  by  exsanguination  by  a
ection  of  the  neck  vessels  to  facilitate  identiﬁcation  and
emoval  of  the  left  hemidiaphragm  and  the  phrenic  nerve
orresponding  portion.  Bulbring11 technique  was  used  to
valuate  the  effect  of  ropivacaine  on  neuromuscular  trans-
ission,  its  inﬂuence  on  blockade  produced  by  pancuronium
nd  the  effectiveness  of  neostigmine  and  4-aminopyridine
n  neuromuscular  blockade  reversal.  The  preparations  were
xed  in  a  vat  containing  40  mL  nutritious  Tyrode  solu-
ion,  continuously  aerated  with  carbogen  (95%  O2 +  5%  CO2)
nd  maintained  at  37 ◦C.  The  nerve  was  placed  over  plat-
num  electrodes  connected  to  a  Grass  S48  stimulator.  The
iaphragm  was  maintained,  by  its  tendinous  portion,  under
onstant  voltage  (5.0  g)  via  wire  connected  to  isometric
ransducer  Load  Cell  BG50  GMS  and  subjected  to  indirect
timulation  of  0.1  Hz  frequency  and  duration  of  0.2  ms,  and
he  voltage  variations  produced  by  diaphragm  contractions
ere  recorded  in  physiograph  Gould  RS  3400.  To  evalu-
te  the  effect  of  drugs  used  alone  and  in  combination
n  neuromuscular  transmission,  three  groups  were  formed
n  =  5):  Group  I,  ropivacaine  (5  g  mL−1);  Group  II,  pancuro-
ium  (2  g  mL−1);  and  Group  III,  pancuronium  (2  g  mL−1)  in
reparation  previously  exposed  to  ropivacaine  (5  g  mL−1).
n  Group  III  (pancuronium--ropivacaine),  pancuronium  was
dded  to  the  preparation  30  min  after  the  addition  of  ropiva-
aine.  Muscle  response  to  indirect  stimulation  was  recorded
or  60  min  after  addition  of  the  drugs.
The  same  preparation  was  used  to  study  the  effectiveness
f  the  drugs  (neostigmine  --  2  g  mL−1 and  4-aminopriridina
-  20  g  mL−1)  on  neuromuscular  blockade  reversal,  which
ere  added  to  the  preparation  after  the  blockade  pro-
uced  by  ropivacaine-pancuronium  combination.  In  the
at  diaphragm,  the  effects  of  ropivacaine  on  miniature
ndplate  potentials  and  membrane  potentials  were  also
tudied.  Parameters  evaluated  were  (1)  extent  of  diaphragm
h
t
aigure  2  Degree  of  blockade  with  pancuronium  alone  and  in
reparation  previously  exposed  to  ropivacaine.
uscle  response  to  indirect  stimulation  before  and  60  min
fter  ropivacaine  addition;  (2)  extent  of  diaphragm  mus-
le  response  to  indirect  stimulation  before  and  60  min
fter  pancuronium  addition,  alone  and  previously  combined
ith  ropivacaine;  (3)  membrane  potentials  (MP)  and  minia-
ure  endplate  potentials  (MEPP);  and  (4)  effectiveness  of
eostigmine  and  4-aminopyridine  on  neuromuscular  block-
de  reversal.
Results  were  expressed  as  means  and  standard  devia-
ions.  Wilcoxon  test  was  used  to  analyze  the  membrane
otential  of  muscle  ﬁber  and  the  effectiveness  of  neuromus-
ular  blockade  reversal  drugs.  To  evaluate  the  reduction  in
he  extent  of  muscle  response,  Student’s  t-test  (normal  dis-
ribution)  was  used.  A  signiﬁcant  level  of  5%  (p  <  0.05)  was
ssumed.  The  power  of  the  test  was  calculated  and  ˇ  >  20%
power  >  80%)  was  obtained.
esults
t  the  concentration  studied  and  used  alone,  ropivacaine
id  not  reduce  the  extent  of  muscle  response  to  indirect
lectrical  stimulation  on  rat  phrenic  nerve-diaphragm.  With
ancuronium  alone  and  in  preparations  previously  exposed
o  ropivacaine,  the  mean  extent  of  muscle  responses  was
5.1%  and  6.2%,  respectively,  and  the  corresponding  block-
de  was  54.9  ±  14.1  and  93.8%  ±  9.2%,  respectively,  with
igniﬁcant  difference  (p  =  0.015)  (Figs.  1  and  2).
The  neuromuscular  blockade  caused  by  pancuronium
n  preparations  exposed  to  ropivacaine  was  both  partially
nd  fully  reversed  by  neostigmine  and  4-aminopyridine,
espectively.
There  was  no  signiﬁcant  effect  of  ropivacaine  on  mem-
rane  potentials  (Fig.  3).  Effects  on  miniature  endplate
otentials  (MEPP)  were  characterized  by  a decrease  in  fre-
uency  and  extent  until  complete  blockade.
iscussion
he  effects  of  local  anesthetics  on  neuromuscular  junction
nd  its  inﬂuence  on  the  blockade  produced  by  nondepolar-owever,  this  interaction  has  been  described  in  experimen-
al  and  human  studies.1--7,12 Experimental  studies5--7,13 serve
s  the  basis  for  the  results  observed  in  the  clinic,  with  the
Effect  of  ropivacaine-pancuronium  on  neuromuscular  transmissio
100
90
80
70
60
50
M
em
br
an
e 
po
te
nt
ia
l (–
mV
)
Time (min)
Ropivacaine (5 mcg/mL)
0 10 20 30 40 50 60
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ipotential  in  the  rat  diaphragm  preparation.
advantage  of  eliminating  bias,  which  is  the  great  individual
variability  in  response  to  neuromuscular  blockers.10,14
Although  local  anesthetics  can  only  produce  neuromus-
cular  blockade  at  high  doses,  interactions  with  neuro-
muscular  blockers,  particularly  non-depolarizing,  become
clinically  relevant,  and  careful  observation  is  required
when  using  these  agents  simultaneously,  or  in  situations
where  the  safety  margin  of  neuromuscular  transmission  is
reduced.1--4,12,14,15
Several  mechanisms  are  admitted  to  explain  the
interaction  between  local  anesthetics  and  neuromuscu-
lar  blockers:  in  the  presynaptic  region,  it  selectively
depresses  conduction  in  motor  ﬁbers  and  inhibits  the
acetylcholine  release  during  nerve  stimulation;  at  the  post-
synaptic  level,  local  anesthetics  may  bind  to  different
speciﬁc  acetylcholine  sites,  resulting  in  desensitization  of
receptors,  and  may  cause  temporary  occlusion  of  nico-
tinic  receptor  channels;  furthermore,  a  stabilizing  action
of  postjunctional  membrane  and  the  interference  with
the  muscular  ﬁber  excitation-contraction  mechanism  are
described.5--7,11,13,16--19
The  ropivacaine  concentration  used  was  established  in  a
pilot  study  and  determined  from  data  presented  in  stud-
ies  carried  out  in  Brazil,  where  other  amino-amide  local
anesthetics  with  similar  characteristics  to  ropivacaine  were
used.6,7 Matsuo  et  al.13 evaluated,  in  preparation  similar  to
that  used  in  this  study,  the  association  of  d-tubocurarine
with  different  local  anesthetics  and  found  that,  even  in
ineffective  concentrations,  local  anesthetics  potentiated
neuromuscular  blocker,  as  evidenced  by  signiﬁcant  decrease
in  the  ED50.  Regarding  the  inﬂuence  of  neuromuscular  block-
ers  on  the  effects  local  anesthetics,  these  authors  also
reported  that  ineffective  concentrations  of  d-tubocurarine
caused  a  similar  decrease  of  ED50  and  increase  of  local  anes-
thetic  potency.
In  a  clinical  trial,  Sahin  et  al.4 evaluated  the  charac-
teristics  of  neuromuscular  block  produced  by  vecuronium
in  patients  undergoing  general  anesthesia  combined  with
epidural  block  with  0.5%  levobupivacaine  (15  mL)  and
observed  a  signiﬁcant  increase  in  the  rate  of  recovery  and
total  duration  of  vecuronium  effect,  without,  however,  inﬂu-
encing  its  clinical  duration  (CD25%).  These  ﬁndings  may
be  explained  by  the  fact  that  levobupivacaine  metabolism,
when  used  in  epidural  space,  only  occurs  in  approximately
30  min  when  the  drug  reaches  the  circulation.1
C
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The  present  study  showed  that  ropivacaine,  at  the
oncentration  studied,  administered  alone  had  no  effect  on
euromuscular  junction;  however,  it  potentiated  the  block-
de  produced  by  pancuronium.  These  results  are  similar  to
hose  of  other  authors,  who  found  no  clinical  impairment
n  neuromuscular  transmission  in  experimental  studies  with
he  isolated  use  of  different  local  anesthetics.  However,  a
lear  potentiation  of  the  effect  of  various  neuromuscular
lockers  has  been  described  as  a result  of  these  drugs  com-
ination,  an  interaction  that  may  be  consequential  to  the
rue  potentiation  at  different  locations  of  the  neuromus-
ular  junction,1,2,4--7,12,13,20 caused  by  the  action  of  the  two
rugs
It  is  believed  that  the  greatest  degree  of  neuromuscular
lockade  caused  by  pancuronium  in  rat  diaphragm  prepara-
ions  previously  exposed  to  ropivacaine,  and  evidenced  by
 greater  reduction  in  the  extent  of  muscle  responses  to
hrenic  nerve  stimulation,  is  due  to  a  presynaptic  action
f  ropivacaine  and  not  to  the  muscular  ﬁber  depolariz-
ng  action,  as  it  was  found  in  electrophysiological  studies
hat  bupivacaine  at  the  concentration  used  did  not  modify
he  membrane  potential  of  muscle  ﬁbers.  The  presynaptic
ction  was  demonstrated  by  the  decrease  in  the  frequency
nd  amplitude  of  miniature  endplate  potentials  (MEPP)
aused  by  ropivacaine,  being  the  result  of  changes  in  quantal
elease  of  acetylcholine.
The  neuromuscular  blockade  caused  by  ropivacaine
ombined  with  pancuronium  was  completely  reversed  by  4-
minopyridine  and,  to  a  lesser  extent,  with  neostigmine.
hese  results  were  also  described  by  Sahin  et  al.4 who
bserved  greater  efﬁcacy  of  4-aminopyridine  in  humans
ompared  to  neostigmine  on  blockade  reversal  caused  by
ecuronium  in  patients  receiving  levobupivacaine  in  the
pidural  space.  In  experimental  studies,  similar  results
ere  found  regarding  reversal  of  blockade  caused  by
idocaine--rocuronium  combination.5
By  inhibiting  the  acetylcholinesterase,  neostigmine
ncreases  the  neurotransmitter  concentration  in  the  synap-
ic  cleft,  competitively  displacing  the  agents  causing
lockage.  The  partial  antagonism  of  neostigmine  reinforces
his  ﬁnding,  as  cholinesterase  inhibitors  are  only  effective
n  reversing  the  postsynaptic  block.  The  4-aminopyridine,  in
ddition  to  its  inhibitory  effect  of  endplate  nicotinic  recep-
or  desensitization,  causes  increased  quantal  acetylcholine.
his  increase  is  the  result  of  actions  in  the  membrane  of
erve  endings,  such  as  potassium  channel  inhibition,  which
roduces  an  increase  in  the  duration  of  the  action  poten-
ial  and  increased  inﬂux  of  calcium  ions  to  motor  nerve
ndings  during  membrane  depolarization.21--23 The  complete
ntagonism  achieved  with  4-aminopyridine  suggested  that
opivacaine  interaction  with  pancuronium  has  presynaptic
omponent  related  to  decreased  acetylcholine  release.
Ropivacaine  alone  did  not  compromise  neuromuscular
ransmission,  but  potentiated  the  blockade  produced  by
ancuronium,  which  was  reversed  by  neostigmine  and  4-
minopyridine.  These  ﬁndings  are  important  for  clinical
ractice  because  it  provides  guidance  on  the  need  for  mon-
toring,  particularly  when  combined  with  other  drugs.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
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